BlackRock Health Sciences Term Trust $BMEZ Position Increased by Rivernorth Capital Management LLC

Rivernorth Capital Management LLC boosted its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 24.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 809,196 shares of the company’s stock after buying an additional 160,629 shares during the quarter. Rivernorth Capital Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $11,620,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Kestra Advisory Services LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the 4th quarter worth $26,000. SouthState Bank Corp acquired a new stake in shares of BlackRock Health Sciences Term Trust during the first quarter worth $29,000. PNC Financial Services Group Inc. acquired a new stake in shares of BlackRock Health Sciences Term Trust during the first quarter worth $35,000. Geneos Wealth Management Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the first quarter valued at $40,000. Finally, Allworth Financial LP boosted its position in shares of BlackRock Health Sciences Term Trust by 24,584.6% in the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after purchasing an additional 3,196 shares during the period.

BlackRock Health Sciences Term Trust Price Performance

Shares of BMEZ opened at $15.46 on Wednesday. The business’s 50-day moving average price is $14.88 and its 200 day moving average price is $14.72. BlackRock Health Sciences Term Trust has a 1-year low of $13.67 and a 1-year high of $15.80.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be issued a $0.11 dividend. This represents a c) annualized dividend and a dividend yield of 8.5%. The ex-dividend date is Tuesday, September 15th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.